Filters

SPINK7 Antibody

SPINK7 Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameSPINK7 Primary Polyclonal Antibody
Also known asSPINK7 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenSPINK7
SpecificityThis is a highly specific antibody against SPINK7
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range50-85/85
Subcellular locationSecreted
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human SPINK7
Gene ID number84651
Swiss ProtP58062
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivityHuman
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigenProbable serine protease inhibitor
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names ECRG-2, ECRG2, Esophagus cancer-related gene 2 protein, SPINK7, Serine protease inhibitor Kazal-type 7, UNQ745/PRO1474, ECG2
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetSPINK7
Short nameSPINK7 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameSPINK7 (Antibody to)
Alternative techniqueantibodies
Identity 24643
Gene SPINK7
Long gene name Kazal type 7 (putative) , serine peptidase inhibitor
Synonyms ECG2 ECRG2
Synonyms name esophagus cancer related gene 2
Locus 5q32
Discovery year 2006-02-20
Entrez gene record 84651
Pubmed identfication 12646258 12970870
RefSeq identity NM_032566
Classification Kazal type , Serine peptidase inhibitors
Havana BLAST/BLAT OTTHUMG00000163522

Subscribe to our Newsletter